MetaCap

Avantor (AVTR) vs Revvity (RVTY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Revvity (RVTY) has outperformed Avantor (AVTR) over the past year, gaining 47.8% versus a gain of 28.8%. Over five years, RVTY leads with a -20.7% price change compared with -62.5% for AVTR. Revvity is the larger company by market cap ($16.21 billion vs $10.06 billion), about 1.6 times the size.

On valuation, Avantor trades at a lower forward P/E (16.7x vs 24.4x for Revvity). Revvity pays a dividend yielding 0.19%, while Avantor does not currently pay one. Revvity converts more of its revenue into profit, with a net margin of 8.4% versus -8.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AVTR+28.82%RVTY+47.78%
+74%+17%-41%
Nov 21, 20251 yearNov 20, 2026
AVTR-62.58%RVTY-23.09%
+11%-37%-86%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AVTR versus RVTY key metrics
MetricAVTRRVTY
Share price$14.84$145.22
Market cap$10.06B$16.21B
1-day change-1.85%-4.20%
YTD return+29.49%+50.10%
1-year return+28.82%+47.78%
5-year return-62.54%-20.68%
P/E ratio (TTM)29.6864.54
Forward P/E16.7324.38
EPS (TTM)$0.50$2.25
Dividend yield0.00%0.19%
Annual dividend$0.00$0.28
Revenue (latest FY)$6.55B$2.86B
Revenue growth (YoY)-3.41%+3.67%
Net income (latest FY)$-530.20M$241.20M
Gross margin32.65%—
Operating margin-3.76%12.49%
Net margin-8.09%8.45%
52-week high$17.45$171.74
52-week low$7.27$81.22
Distance from 52-week high-14.96%-15.44%
Analyst consensusholdbuy
Avg. price target upside+16.91%+18.03%
Average volume8.77M1.91M
Shares outstanding677.62M111.64M
Employees13,50011,000
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RVTY has outperformed AVTR by 19.0 percentage points over the past year.
  • Revvity trades at a higher earnings multiple (64.5x vs 29.7x trailing P/E).
  • Revvity is more profitable, keeping 8.4 cents of every revenue dollar as net income versus -8.1 cents for Avantor.
  • Revvity grew revenue faster in its latest fiscal year (+3.67% vs -3.41%).

About Avantor

AVTR stock →

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Industrials · Biotechnology: Laboratory Analytical Instruments · 13,500 employees

About Revvity

RVTY stock →

Revvity, Inc. provides health sciences solutions, technologies, and services.

Industrials · Biotechnology: Laboratory Analytical Instruments · 11,000 employees

AVTR vs RVTY FAQ

Which is bigger, Avantor or Revvity?

Revvity (RVTY) is larger, with a market capitalization of $16.21B compared with $10.06B for Avantor (AVTR).

Which stock has performed better over the past year, AVTR or RVTY?

RVTY returned +47.78% over the past 12 months, compared with +28.82% for AVTR (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, AVTR or RVTY?

AVTR has the lower trailing P/E at 29.7, versus 64.5 for RVTY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Avantor or Revvity?

Revvity pays a dividend yielding 0.19%, while Avantor does not currently pay a regular dividend.

Are Avantor and Revvity in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons